1mxo: Difference between revisions
New page: left|200px<br /><applet load="1mxo" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mxo, resolution 1.83Å" /> '''AmpC beta-lactamase ... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1mxo.jpg|left|200px]]<br /><applet load="1mxo" size=" | [[Image:1mxo.jpg|left|200px]]<br /><applet load="1mxo" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="1mxo, resolution 1.83Å" /> | caption="1mxo, resolution 1.83Å" /> | ||
'''AmpC beta-lactamase in complex with an m.carboxyphenylglycylboronic acid bearing the cephalothin R1 side chain'''<br /> | '''AmpC beta-lactamase in complex with an m.carboxyphenylglycylboronic acid bearing the cephalothin R1 side chain'''<br /> | ||
==Overview== | ==Overview== | ||
beta-lactamases are the most widespread resistance mechanism to | beta-lactamases are the most widespread resistance mechanism to beta-lactam antibiotics, such as the penicillins and the cephalosporins. In an effort to combat these enzymes, a combination of stereoselective organic synthesis, enzymology, microbiology, and X-ray crystallography was used to design and evaluate new carboxyphenyl-glycylboronic acid transition-state analogue inhibitors of the class C beta-lactamase AmpC. The new compounds improve inhibition by over 2 orders of magnitude compared to analogous glycylboronic acids, with K(i) values as low as 1 nM. On the basis of the differential binding of different analogues, the introduced carboxylate alone contributes about 2.1 kcal/mol in affinity. This carboxylate corresponds to the ubiquitous C3(4)' carboxylate of beta-lactams, and this energy represents the first thermodynamic measurement of the importance of this group in molecular recognition by class C beta-lactamases. The structures of AmpC in complex with two of these inhibitors were determined by X-ray crystallography at 1.72 and 1.83 A resolution. These structures suggest a structural basis for the high affinity of the new compounds and provide templates for further design. The highest affinity inhibitor was 5 orders of magnitude more selective for AmpC than for characteristic serine proteases, such as chymotrypsin. This inhibitor reversed the resistance of clinical pathogens to the third generation cephalosporin ceftazidime; it may serve as a lead compound for drug discovery to combat bacterial resistance to beta-lactam antibiotics. | ||
==About this Structure== | ==About this Structure== | ||
1MXO is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with PO4 and SM2 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http:// | 1MXO is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=PO4:'>PO4</scene> and <scene name='pdbligand=SM2:'>SM2</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MXO OCA]. | ||
==Reference== | ==Reference== | ||
Line 16: | Line 16: | ||
[[Category: Blazquez, J.]] | [[Category: Blazquez, J.]] | ||
[[Category: Caselli, E.]] | [[Category: Caselli, E.]] | ||
[[Category: Focia, P | [[Category: Focia, P J.]] | ||
[[Category: Morandi, F.]] | [[Category: Morandi, F.]] | ||
[[Category: Morandi, S.]] | [[Category: Morandi, S.]] | ||
[[Category: Prati, F.]] | [[Category: Prati, F.]] | ||
[[Category: Shoichet, B | [[Category: Shoichet, B K.]] | ||
[[Category: PO4]] | [[Category: PO4]] | ||
[[Category: SM2]] | [[Category: SM2]] | ||
Line 28: | Line 28: | ||
[[Category: serine hydrolase]] | [[Category: serine hydrolase]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:00:07 2008'' |